Safety and Efficacy of Bronchitol in Bronchiectasis
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Study will assess the safety and effectiveness of 12 week treatment with the study
medication, Bronchitol, in subjects with bronchiectasis (a lung disease where patients have
trapped, and often infected, thick, sticky mucus). Past studies have shown Bronchitol
inhalation may help to facilitate the clearance of mucus by altering its rheology (making it
less thick and sticky), thereby enhancing the shift of stagnant mucus from the lungs. On
completion of the double blind phase, subjects will have the opportunity to participate in a
52 week open label phase.